GI tumors have a highly immunosuppressive TME that is partly attributed to inhibitory cytokines, including TGFβ secreted by suppressive regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages, which can result in reduced effector function of T cells and CAR-T cells (19). The gene discussed is TGFB1; the disease is digestive system neoplasm.